CNINE BIOSOLUTIONS, INC.

BIRMINGHAM, AL · Founded 2013 · Medtech · Private

sMAC lateral flow assay diagnostic for rapid detection of bacterial meningitis and CNS infections

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: BIRMINGHAM, AL
Founded: 2013
Latest Form D: $400K, Dec 2017
Total capital: $749K

Federal grants: $349K; 2 awards · 2017–2018; Rank in peer group#78 of 95
Private capital raised: $400K; 1 Form D · last Dec 2017; 106 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Jan 2018Federal grantHealth and Human S · Phase I · Inexpensive, sensitive and specific, point-of-care diagnostic for bacterial infections in the central nervous system$77K
Dec 2017Private capital raisedForm D · SEC · 1st filing$400K
Jan 2017Federal grantHealth and Human S · Phase I · Inexpensive, sensitive and specific, point-of-care diagnostic for bacterial infections in the central nervous system$272K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

10months

from CNINE BIOSOLUTIONS, INC.’s first federal award to its first private round.

First federal award · Jan 2017: Health and Human S · $272K
First Form D · Dec 2017: $400K · 1st Form D
Awards before first raise: 1 award

An association in public records, not a cause or a prediction.

Standing among 95 peers

Line = median

Medtech · Instrument

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Theresa N. ScheinResearcherExecutive Officer, DirectorLinked by $349K in grants as PI
Baird M. OldfieldDirectorNamed in SEC Form D filings
James M. JohnstonExecutive OfficerNamed in SEC Form D filings
Scott R. BarnumExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Capillary Biomedical, Inc.Similar federal contract value in Medtech · null in contracts
NOVUSON SURGICAL, INC.Similar federal contract value in Medtech · null in contracts
THERMIMAGE, INC.Similar federal contract value in Medtech · null in contracts
Happy Medium Development Ltd Liability CoSimilar federal contract value in Medtech · null in contracts
SHAPE MEDICAL SYSTEMS, INC.Similar federal contract value in Medtech · null in contracts
Enspectra Health, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.